Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuromyelitis Optica Spectrum Disease (NMOSD)”

82 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 82 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07699770
What this trial is testing

Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)Neuropathic Pain
Tang-Du Hospital 110
Not applicableNot Yet RecruitingNCT06903130
What this trial is testing

Clinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sNfL) and Glial Fibrillary Acidic Protein (sGFAP) Levels in Patients With Aquaporin-4-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
NMOSD
National and Kapodistrian University of Athens 40
Not applicableStudy completedNCT05871658
What this trial is testing

Efficacy of Electroacupuncture in NMOSD Patients With Pain: Study Protocol

Who this might be right for
Neuromyelitis Optica Spectrum DisordersPain
Yuanqi Zhao,MD 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05314010
What this trial is testing

MIL62 in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Beijing Mabworks Biotech Co., Ltd. 102
Testing effectiveness (Phase 2)Looking for participantsNCT05504694
What this trial is testing

Ofatumumab in AQP4-IgG Seropositive NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Tang-Du Hospital 5
Not applicableLooking for participantsNCT07653984
What this trial is testing

Cohort Study on Neuroimmune Diseases in the Reproductive Age

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)Multiple SclerosisAutoimmune Encephalitis+3 more
Third Affiliated Hospital, Sun Yat-Sen University 100
Early research (Phase 1)Study completedNCT02276963
What this trial is testing

Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Johns Hopkins University 6
Not applicableLooking for participantsNCT06865274
What this trial is testing

Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMOGADMultiple Sclerosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Early research (Phase 1)Not Yet RecruitingNCT07341828
What this trial is testing

C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disorders (NMOSD)Autoimmune Encephalitis+1 more
Huashan Hospital 15
Not applicableLooking for participantsNCT05909761
What this trial is testing

Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy

Who this might be right for
Neuromyelitis Optica Spectrum DisorderPregnancy Related
Amgen 60
Large-scale testing (Phase 3)Study completedNCT02073279
What this trial is testing

Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica (NMO)NMO Spectrum Disorder (NMOSD)
Hoffmann-La Roche 95
Not applicableStudy completedNCT06888622
What this trial is testing

BLAZE-Limiting Approach in NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)
Huashan Hospital 9
Not applicableNot Yet RecruitingNCT07182409
What this trial is testing

Efficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
NMOSD
First Affiliated Hospital of Chongqing Medical University 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05403138
What this trial is testing

Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderNMO Spectrum Disorder
Tianjin Medical University General Hospital 135
Early research (Phase 1)Not Yet RecruitingNCT06633042
What this trial is testing

The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD

Who this might be right for
Autoimmune Disease
Bioray Laboratories 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07809724
What this trial is testing

Efficacy and Safety of Low-Dose IL-2 in Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Peking University People's Hospital 60
Testing effectiveness (Phase 2)UnknownNCT06497374
What this trial is testing

FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderNMO Spectrum Disorder
Tianjin Medical University General Hospital 63
Post-approval studies (Phase 4)Not Yet RecruitingNCT07010302
What this trial is testing

Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD

Who this might be right for
NMOSD
Massachusetts General Hospital 540
Testing effectiveness (Phase 2)Study completedNCT03062579
What this trial is testing

A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum DisordersNeuromyelitis OpticaDevic's Disease
Fu-Dong Shi 10
Not applicableStudy completedNCT07032337
What this trial is testing

Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Samsung Medical Center 2,985
Next Page